The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infectious Disease Testing And Diagnostic Market Research Report 2025
Synopsis
Infectious disease testing is the process of identification of causative organisms for the primary diagnosis of diseases.
The global Infectious Disease Testing And Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Testing And Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Testing And Diagnostic.
Report Scope
The Infectious Disease Testing And Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Testing And Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Testing And Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Danaher Corporation
Bio-Rad Laboratories
bioMérieux
Thermo Fisher Scientific
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
DiaSorin
Meridian Bioscience
Quidel Corporation
Segment by Type
Immunodiagnostics
Clinical Microbiology
Polymerase Chain Reaction
Next Generation Sequencing
Others
Segment by Application
Hospital and Clinical Laboratories
Academics and Research Institutes
Reference Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Testing And Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Infectious disease testing is the process of identification of causative organisms for the primary diagnosis of diseases.
The global Infectious Disease Testing And Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Testing And Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Testing And Diagnostic.
Report Scope
The Infectious Disease Testing And Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Testing And Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Testing And Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Danaher Corporation
Bio-Rad Laboratories
bioMérieux
Thermo Fisher Scientific
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
DiaSorin
Meridian Bioscience
Quidel Corporation
Segment by Type
Immunodiagnostics
Clinical Microbiology
Polymerase Chain Reaction
Next Generation Sequencing
Others
Segment by Application
Hospital and Clinical Laboratories
Academics and Research Institutes
Reference Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Testing And Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Testing And Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunodiagnostics
1.2.3 Clinical Microbiology
1.2.4 Polymerase Chain Reaction
1.2.5 Next Generation Sequencing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Infectious Disease Testing And Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital and Clinical Laboratories
1.3.3 Academics and Research Institutes
1.3.4 Reference Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Testing And Diagnostic Market Perspective (2019-2030)
2.2 Infectious Disease Testing And Diagnostic Growth Trends by Region
2.2.1 Global Infectious Disease Testing And Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Testing And Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Testing And Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Testing And Diagnostic Market Dynamics
2.3.1 Infectious Disease Testing And Diagnostic Industry Trends
2.3.2 Infectious Disease Testing And Diagnostic Market Drivers
2.3.3 Infectious Disease Testing And Diagnostic Market Challenges
2.3.4 Infectious Disease Testing And Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Testing And Diagnostic Players by Revenue
3.1.1 Global Top Infectious Disease Testing And Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease Testing And Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Testing And Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Testing And Diagnostic Revenue
3.4 Global Infectious Disease Testing And Diagnostic Market Concentration Ratio
3.4.1 Global Infectious Disease Testing And Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Testing And Diagnostic Revenue in 2023
3.5 Infectious Disease Testing And Diagnostic Key Players Head office and Area Served
3.6 Key Players Infectious Disease Testing And Diagnostic Product Solution and Service
3.7 Date of Enter into Infectious Disease Testing And Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Testing And Diagnostic Breakdown Data by Type
4.1 Global Infectious Disease Testing And Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Testing And Diagnostic Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Testing And Diagnostic Breakdown Data by Application
5.1 Global Infectious Disease Testing And Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Testing And Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Testing And Diagnostic Market Size (2019-2030)
6.2 North America Infectious Disease Testing And Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease Testing And Diagnostic Market Size by Country (2019-2024)
6.4 North America Infectious Disease Testing And Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Testing And Diagnostic Market Size (2019-2030)
7.2 Europe Infectious Disease Testing And Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease Testing And Diagnostic Market Size by Country (2019-2024)
7.4 Europe Infectious Disease Testing And Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Testing And Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease Testing And Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease Testing And Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease Testing And Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Testing And Diagnostic Market Size (2019-2030)
9.2 Latin America Infectious Disease Testing And Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease Testing And Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease Testing And Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Testing And Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease Testing And Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease Testing And Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease Testing And Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Infectious Disease Testing And Diagnostic Introduction
11.1.4 Abbott Laboratories Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Detail
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Infectious Disease Testing And Diagnostic Introduction
11.2.4 Danaher Corporation Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.2.5 Danaher Corporation Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Infectious Disease Testing And Diagnostic Introduction
11.3.4 Bio-Rad Laboratories Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Detail
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Infectious Disease Testing And Diagnostic Introduction
11.4.4 bioMérieux Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.4.5 bioMérieux Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Infectious Disease Testing And Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 F. Hoffmann-La Roche AG
11.6.1 F. Hoffmann-La Roche AG Company Detail
11.6.2 F. Hoffmann-La Roche AG Business Overview
11.6.3 F. Hoffmann-La Roche AG Infectious Disease Testing And Diagnostic Introduction
11.6.4 F. Hoffmann-La Roche AG Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.6.5 F. Hoffmann-La Roche AG Recent Development
11.7 Becton, Dickinson and Company
11.7.1 Becton, Dickinson and Company Company Detail
11.7.2 Becton, Dickinson and Company Business Overview
11.7.3 Becton, Dickinson and Company Infectious Disease Testing And Diagnostic Introduction
11.7.4 Becton, Dickinson and Company Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.7.5 Becton, Dickinson and Company Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Detail
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Infectious Disease Testing And Diagnostic Introduction
11.8.4 DiaSorin Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.8.5 DiaSorin Recent Development
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Detail
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Infectious Disease Testing And Diagnostic Introduction
11.9.4 Meridian Bioscience Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.9.5 Meridian Bioscience Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Detail
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Infectious Disease Testing And Diagnostic Introduction
11.10.4 Quidel Corporation Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024)
11.10.5 Quidel Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Infectious Disease Testing And Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunodiagnostics
Table 3. Key Players of Clinical Microbiology
Table 4. Key Players of Polymerase Chain Reaction
Table 5. Key Players of Next Generation Sequencing
Table 6. Key Players of Others
Table 7. Global Infectious Disease Testing And Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Infectious Disease Testing And Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Infectious Disease Testing And Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Infectious Disease Testing And Diagnostic Market Share by Region (2019-2024)
Table 11. Global Infectious Disease Testing And Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Infectious Disease Testing And Diagnostic Market Share by Region (2025-2030)
Table 13. Infectious Disease Testing And Diagnostic Market Trends
Table 14. Infectious Disease Testing And Diagnostic Market Drivers
Table 15. Infectious Disease Testing And Diagnostic Market Challenges
Table 16. Infectious Disease Testing And Diagnostic Market Restraints
Table 17. Global Infectious Disease Testing And Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Infectious Disease Testing And Diagnostic Market Share by Players (2019-2024)
Table 19. Global Top Infectious Disease Testing And Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing And Diagnostic as of 2023)
Table 20. Ranking of Global Top Infectious Disease Testing And Diagnostic Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Infectious Disease Testing And Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Infectious Disease Testing And Diagnostic Product Solution and Service
Table 24. Date of Enter into Infectious Disease Testing And Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infectious Disease Testing And Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Infectious Disease Testing And Diagnostic Revenue Market Share by Type (2019-2024)
Table 28. Global Infectious Disease Testing And Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Infectious Disease Testing And Diagnostic Revenue Market Share by Type (2025-2030)
Table 30. Global Infectious Disease Testing And Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Infectious Disease Testing And Diagnostic Revenue Market Share by Application (2019-2024)
Table 32. Global Infectious Disease Testing And Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Infectious Disease Testing And Diagnostic Revenue Market Share by Application (2025-2030)
Table 34. North America Infectious Disease Testing And Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Infectious Disease Testing And Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Infectious Disease Testing And Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Infectious Disease Testing And Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Infectious Disease Testing And Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Infectious Disease Testing And Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Infectious Disease Testing And Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Infectious Disease Testing And Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Infectious Disease Testing And Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Infectious Disease Testing And Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Infectious Disease Testing And Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Infectious Disease Testing And Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Infectious Disease Testing And Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Infectious Disease Testing And Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Infectious Disease Testing And Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 49. Abbott Laboratories Company Detail
Table 50. Abbott Laboratories Business Overview
Table 51. Abbott Laboratories Infectious Disease Testing And Diagnostic Product
Table 52. Abbott Laboratories Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 53. Abbott Laboratories Recent Development
Table 54. Danaher Corporation Company Detail
Table 55. Danaher Corporation Business Overview
Table 56. Danaher Corporation Infectious Disease Testing And Diagnostic Product
Table 57. Danaher Corporation Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 58. Danaher Corporation Recent Development
Table 59. Bio-Rad Laboratories Company Detail
Table 60. Bio-Rad Laboratories Business Overview
Table 61. Bio-Rad Laboratories Infectious Disease Testing And Diagnostic Product
Table 62. Bio-Rad Laboratories Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 63. Bio-Rad Laboratories Recent Development
Table 64. bioMérieux Company Detail
Table 65. bioMérieux Business Overview
Table 66. bioMérieux Infectious Disease Testing And Diagnostic Product
Table 67. bioMérieux Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 68. bioMérieux Recent Development
Table 69. Thermo Fisher Scientific Company Detail
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Infectious Disease Testing And Diagnostic Product
Table 72. Thermo Fisher Scientific Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Development
Table 74. F. Hoffmann-La Roche AG Company Detail
Table 75. F. Hoffmann-La Roche AG Business Overview
Table 76. F. Hoffmann-La Roche AG Infectious Disease Testing And Diagnostic Product
Table 77. F. Hoffmann-La Roche AG Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 78. F. Hoffmann-La Roche AG Recent Development
Table 79. Becton, Dickinson and Company Company Detail
Table 80. Becton, Dickinson and Company Business Overview
Table 81. Becton, Dickinson and Company Infectious Disease Testing And Diagnostic Product
Table 82. Becton, Dickinson and Company Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 83. Becton, Dickinson and Company Recent Development
Table 84. DiaSorin Company Detail
Table 85. DiaSorin Business Overview
Table 86. DiaSorin Infectious Disease Testing And Diagnostic Product
Table 87. DiaSorin Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 88. DiaSorin Recent Development
Table 89. Meridian Bioscience Company Detail
Table 90. Meridian Bioscience Business Overview
Table 91. Meridian Bioscience Infectious Disease Testing And Diagnostic Product
Table 92. Meridian Bioscience Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 93. Meridian Bioscience Recent Development
Table 94. Quidel Corporation Company Detail
Table 95. Quidel Corporation Business Overview
Table 96. Quidel Corporation Infectious Disease Testing And Diagnostic Product
Table 97. Quidel Corporation Revenue in Infectious Disease Testing And Diagnostic Business (2019-2024) & (US$ Million)
Table 98. Quidel Corporation Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Testing And Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Infectious Disease Testing And Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Immunodiagnostics Features
Figure 4. Clinical Microbiology Features
Figure 5. Polymerase Chain Reaction Features
Figure 6. Next Generation Sequencing Features
Figure 7. Others Features
Figure 8. Global Infectious Disease Testing And Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Infectious Disease Testing And Diagnostic Market Share by Application: 2023 VS 2030
Figure 10. Hospital and Clinical Laboratories Case Studies
Figure 11. Academics and Research Institutes Case Studies
Figure 12. Reference Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Infectious Disease Testing And Diagnostic Report Years Considered
Figure 15. Global Infectious Disease Testing And Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Infectious Disease Testing And Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Infectious Disease Testing And Diagnostic Market Share by Region: 2023 VS 2030
Figure 18. Global Infectious Disease Testing And Diagnostic Market Share by Players in 2023
Figure 19. Global Top Infectious Disease Testing And Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing And Diagnostic as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Testing And Diagnostic Revenue in 2023
Figure 21. North America Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Infectious Disease Testing And Diagnostic Market Share by Country (2019-2030)
Figure 23. United States Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Infectious Disease Testing And Diagnostic Market Share by Country (2019-2030)
Figure 27. Germany Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Infectious Disease Testing And Diagnostic Market Share by Region (2019-2030)
Figure 35. China Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Infectious Disease Testing And Diagnostic Market Share by Country (2019-2030)
Figure 43. Mexico Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Infectious Disease Testing And Diagnostic Market Share by Country (2019-2030)
Figure 47. Turkey Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Infectious Disease Testing And Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 50. Danaher Corporation Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 52. bioMérieux Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 54. F. Hoffmann-La Roche AG Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 55. Becton, Dickinson and Company Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 56. DiaSorin Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 57. Meridian Bioscience Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 58. Quidel Corporation Revenue Growth Rate in Infectious Disease Testing And Diagnostic Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
